The public is once more debating whether the National Health Insurance (NHI) should cover the expenses of pharmacy-only medicine. Benefit payments provided by the NHI for pharmacy-only drugs last year totaled NT$2 billion (US$65.2 million), Ministry of Health and Welfare figures show. The amount is based on a population of about 18.5 million people. If each person was charged NT$200 for the minimum medical service fee, the amount of diagnostic fees would be about NT$3.7 billion, medical and pharmaceutical expenses about NT$1 billion, and self-bearing medical fees about NT$2.7 billion. Altogether, the NHI provided about NT$9.4 billion last year. If the amount could be reduced, the nation would be able to introduce more up-to-date drugs and implement other insurance plans.
Drugs are generally classified into three categories: drugs with higher risk, stronger efficacy and greater side effects are designated as prescription drugs; milder ones are classified as pharmacy-only drugs; and the rest are over-the-counter drugs.
Some say that if the NHI stops covering pharmacy-only medicine, it would infringe on people’s right to pharmaceutical services and the probability of treatment delays would increase.
That is an arbitrary judgement, as all pharmacy-only drugs must go through three stages of clinical trials; their safety is guaranteed by every country.
Moreover, pharmacists in local drugstores remind their customers to see a doctor immediately if the medicine does not work well. This is how levels of healthcare and responsible self-medication are practiced, and is a standard process in most advanced countries.
However, the nation should consider public opinion before changing the NHI policy. To avoid negative reactions, the NHI should modify insurance plans incrementally.
Furthermore, rather than referring to medical specialty and number of patients as the major criteria, other factors must be taken into account, including the drugs’ safety, indications, timing of use, side effects and clinical necessity. For pharmacy-only medicine that would continue to be covered by the NHI, the government should also help pharmaceutical companies apply for certificates.
Carbomix, for example, is classified as a pharmacy-only drug due to its relative safety, yet it is also used as an emergency treatment. Therefore, Carbomix must be certified as both a prescription and pharmacy-only drug, so that people can purchase it at pharmacies, while its clinical use is covered by the NHI.
The NHI covers 841 items classified as pharmacy-only drugs. The government should remove the outdated ones from the list. Officials should consult academics and medical experts to review those items based on empirical data and accurate statistics.
Meanwhile, as pediatricians have pointed out, drugs for children under the age of 12 should be prescribed by doctors. The issue must be further discussed by officials and experts. If pharmacy-only drugs are covered by the NHI, would that make parents more willing to take their children to a doctor?
Each year, a budget is allocated to the NHI. Taiwan should not go against the international trend by allowing more benefit payments for pharmacy-only drugs. For now, reform should be implemented gradually, but ultimately, Taiwan should follow the example of advanced countries, where pharmacy-only drugs are paid at one’s own expense.
Huang Jin-shun is national policy adviser to the president and president of the Federation of Taiwan Pharmacists’ Associations.
Translated by Emma Liu
The return of US president-elect Donald Trump to the White House has injected a new wave of anxiety across the Taiwan Strait. For Taiwan, an island whose very survival depends on the delicate and strategic support from the US, Trump’s election victory raises a cascade of questions and fears about what lies ahead. His approach to international relations — grounded in transactional and unpredictable policies — poses unique risks to Taiwan’s stability, economic prosperity and geopolitical standing. Trump’s first term left a complicated legacy in the region. On the one hand, his administration ramped up arms sales to Taiwan and sanctioned
The US election result will significantly impact its foreign policy with global implications. As tensions escalate in the Taiwan Strait and conflicts elsewhere draw attention away from the western Pacific, Taiwan was closely monitoring the election, as many believe that whoever won would confront an increasingly assertive China, especially with speculation over a potential escalation in or around 2027. A second Donald Trump presidency naturally raises questions concerning the future of US policy toward China and Taiwan, with Trump displaying mixed signals as to his position on the cross-strait conflict. US foreign policy would also depend on Trump’s Cabinet and
The Taiwanese have proven to be resilient in the face of disasters and they have resisted continuing attempts to subordinate Taiwan to the People’s Republic of China (PRC). Nonetheless, the Taiwanese can and should do more to become even more resilient and to be better prepared for resistance should the Chinese Communist Party (CCP) try to annex Taiwan. President William Lai (賴清德) argues that the Taiwanese should determine their own fate. This position continues the Democratic Progressive Party’s (DPP) tradition of opposing the CCP’s annexation of Taiwan. Lai challenges the CCP’s narrative by stating that Taiwan is not subordinate to the
Republican candidate and former US president Donald Trump is to be the 47th president of the US after beating his Democratic rival, US Vice President Kamala Harris, in the election on Tuesday. Trump’s thumping victory — winning 295 Electoral College votes against Harris’ 226 as of press time last night, along with the Republicans winning control of the US Senate and possibly the House of Representatives — is a remarkable political comeback from his 2020 defeat to US President Joe Biden, and means Trump has a strong political mandate to implement his agenda. What does Trump’s victory mean for Taiwan, Asia, deterrence
RSS